Severe reduction of hearing and vestibular involvement caused by vionactan.
D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D001299:Audiometry; D005260:Female; D006311:Hearing Disorders / Q000139:chemically induced*; D006801:Humans; D008875:Middle Aged; D014722:Vestibule, Labyrinth / Q000187:drug effects*
D000900:Anti-Bacterial Agents